Grupo de Investigación en Cáncer de Mama
NEONCOBREAST
Memorial Sloan Kettering Cancer Center
Nueva York, Estados UnidosPublicacións en colaboración con investigadores/as de Memorial Sloan Kettering Cancer Center (19)
2024
-
A multidisciplinary team and patient perspective on omission of surgery after neoadjuvant systemic therapy for early breast cancer: A European Society of Surgical Oncology (ESSO) Research Academy survey
European Journal of Surgical Oncology, Vol. 50, Núm. 10
2023
-
EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy
European Journal of Cancer, Vol. 181, pp. 79-91
-
Global Cancer Surgery: pragmatic solutions to improve cancer surgery outcomes worldwide
The Lancet Oncology, Vol. 24, Núm. 12, pp. e472-e518
-
The Lucerne Toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensus
eClinicalMedicine, Vol. 61
-
Uncertainties and controversies in axillary management of patients with breast cancer
Cancer Treatment Reviews, Vol. 117
2022
-
Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy
Breast, Vol. 63, pp. 123-139
-
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
Annals of Oncology, Vol. 33, Núm. 12, pp. 1250-1268
2021
-
Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox
The Lancet Oncology, Vol. 22, Núm. 1, pp. e18-e28
-
Evaluation of multiple transcriptomic gene risk signatures in male breast cancer
npj Breast Cancer, Vol. 7, Núm. 1
-
Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial
npj Breast Cancer, Vol. 7, Núm. 1
-
The Impact of the COVID-19 Pandemic on Surgical Management of Breast Cancer: Global Trends and Future Perspectives
Oncologist, Vol. 26, Núm. 1, pp. e66-e77
2020
-
Implementation of the BRESO Theoretical and practical knowledge curriculum for European Breast Surgeons: The time has come
European Journal of Surgical Oncology
2019
-
Breast-implant associated anaplastic large-cell lymphoma. Consensus document (I). Epidemiology, pathogenesis, symptoms and diagnosis
Revista de Senologia y Patologia Mamaria, Vol. 32, Núm. 2, pp. 61-66
2018
-
A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation
EMBO Molecular Medicine, Vol. 10, Núm. 12
-
Characterization of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
Annals of Oncology, Vol. 29, Núm. 2, pp. 405-417
-
Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomy
Breast Cancer Research and Treatment, Vol. 172, Núm. 3, pp. 523-537
-
P95HER2–T cell bispecific antibody for breast cancer treatment
Science Translational Medicine, Vol. 10, Núm. 461
-
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer
Annals of Oncology, Vol. 29, Núm. 5, pp. 1203-1210
2014
-
Effect of p95HER2/611CTF on the response to trastuzumab and chemotherapy
Journal of the National Cancer Institute, Vol. 106, Núm. 11